|
no further attempts are made to
maintain sinus rhythm . 11
The characteristic findings on a
12-lead ECG are the absence of discernible P waves , and QRS complexes that occur at irregular intervals ( see figure 2 ). Given AF ’ s potential to be paroxysmal , the diagnostic yield is increased with ambulatory monitoring using Holter
|
Patrick J Lynch / CC BY 2.5 / bit . ly / 3RBDGfs |
urgently required in anyone with haemodynamically unstable AF , most patients with AF are haemodynamically stable . A decision then needs to be made regarding whether to pursue rhythm or rate control . A rhythm control strategy involves attempting to convert the patient to sinus rhythm and to maintain this rhythm . On the other hand , a rate control strategy |
||||
monitoring ( see figure 3 ), wearable |
attempts to bring the heart rate down |
|||||
devices , smart watches ( see figure 4 ), |
to an acceptable target range which is |
|||||
or implantable loop recorders ( see |
less likely to cause symptoms or ven- |
|||||
figure 5 ). Inpatient cardiac monitor- |
tricular dysfunction . |
|||||
ing ( see figure 6 ) is used in the pres- |
The decision to choose rhythm |
|||||
ence of a TIA and stroke to screen for AF . Longer-term screening for |
or rate control is guided by the patient ’ s individual circumstances . |
|||||
AF with insertable cardiac monitors |
While early rhythm control strat- |
|||||
or non-invasive methods is recom- |
egy , instituted within one year of |
|||||
mended in selected patients , such as |
diagnosis , may reduce the risk of |
|||||
those with embolic stroke of unde- |
cardiovascular death and stroke , it |
|||||
termined source . 12 |
is associated with a higher rate of |
|||||
Regular opportunistic screen- |
complications related to therapy |
|||||
ing for AF is recommended for all patients over the age of 65 . 12 This may be performed by pulse pal- |
such as drug-induced bradycardia , thyroid disease , QT prolongation , and serious but rare complications |
|||||
pation screening for an irregular rhythm , followed by an ECG to confirm the diagnosis . 12 The cost-effectiveness of frequent AF screening in |
of AF ablation ( for example , pericardial tamponade ). 16 Compelling reasons to pursue rhythm control include patient preference , |
|||||
this age group has been confirmed |
high ventricular rates refractory to |
|||||
in multiple analyses . 13 |
attempted rate control , and unpleas- |
|||||
Refer those with newly diag- |
ant symptoms of AF despite ade- |
|||||
nosed AF for a transthoracic echo- |
quate rate control . |
|||||
cardiogram , as information on left |
||||||
atrial size , left ventricular function , |
RATE CONTROL |
|||||
and the presence of mitral stenosis |
Beta blockers , non-dihydropyridine |
|||||
impacts management . Also inves- |
calcium channel blockers ( CCBs ) and |
|||||
tigate for OSA , which has a strong association with AF . 14 Order electrolytes and thyroid stimulating hor- |
digoxin form the backbone of both acute and long-term rate control in AF . Oral beta blockers and non-dihy- |
|||||
mone if the patient is not acutely |
dropyridine CCBs are first-line agents ; |
|||||
unwell ; AF may be the only mani- |
however , their simultaneous use |
|||||
festation of such abnormalities , and |
should be avoided because of the risk |
|||||
may resolve with appropriate treat- |
of complete heart block . Digoxin can |
|||||
ment of the underlying disorder . 12 |
be added to either beta blockers or |
|||||
Routinely screening for CAD in |
non-dihydropyridine CCBs for addi- |
|||||
patients with AF is controversial . It is |
tional rate control , or as a standalone |
|||||
well known that myocardial ischae- |
rate control agent if these two agents |
|||||
mia can trigger AF , that those with AF |
are contraindicated , for example , |
|||||
have higher rates of subclinical CAD compared with the general popula- |
Figure 1 . Left atrial appendage . |
because of symptomatic hypotension .
In addition to its role in rhythm
|
||
tion , and that the presence of CAD affects the management of AF , given the latter is a contraindication to the |
CAD in patients with AF is of benefit . Current guidelines do not make |
MANAGEMENT
THE management of AF is multi-
|
of stroke and management of risk factors . |
control , amiodarone can be useful to slow the rate in the acute setting in patients with highly sympto- |
use of certain antiarrhythmics , such as flecainide . 15 However , there is no evidence that routine screening for |
recommendations regarding routine screening for CAD , beyond performance of a 12-lead ECG
11 , 12
.
|
pronged and includes choice and enactment of rate or rhythm control , prevention |
Rate vs rhythm control
While electrical cardioversion is
|
matic AF or in those with depressed left ventricular systolic function . A reasonable target is a PAGE 40 |
Figure 2 . AF on ECG . |
Ewingdo / CC BY-SA 4.0 / bit . ly / 3RzYRPd |